In a 36-year-old woman with thyroid-stimulating hormone (TSH) 0.56 µIU/mL, follicle-stimulating hormone (FSH) 8.7 IU/L, dehydroepiandrosterone sulfate (DHEA‑S) 170 µg/dL, luteinizing hormone (LH) 4.7 IU/L, progesterone 0.6 ng/mL, prolactin 4.4 ng/mL, estradiol 44 pg/mL, cortisol 7.1 µg/dL, total testosterone 27 ng/dL, and free testosterone 2.4 pg/mL, what is the interpretation of these hormone levels and what are the recommended next steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hormone Panel Interpretation: Low Progesterone with Anovulation Pattern

This hormone panel indicates anovulation with a low progesterone level (0.6 ng/mL) that confirms absent ovulation, requiring immediate assessment of the menstrual cycle phase and clinical context to determine if this represents polycystic ovary syndrome (PCOS), functional hypothalamic amenorrhea, or normal early follicular phase values.

Critical Interpretation Points

Progesterone Analysis

The progesterone level of 0.6 ng/mL is the most significant finding. Mid-luteal progesterone <6 nmol/l (approximately <2 ng/mL) indicates anovulation 1, 2. However, interpretation depends entirely on cycle timing:

  • If drawn during expected mid-luteal phase (days 19-23 of a 28-day cycle): confirms anovulation
  • If drawn during follicular phase (days 3-7): this is normal and expected

Testosterone Assessment

  • Total testosterone: 27 ng/dL (normal range typically 15-70 ng/dL for women)
  • Free testosterone: 2.4 pg/mL

These testosterone values fall within normal limits and do not suggest hyperandrogenism 1. The guidelines emphasize that commercial laboratory reference ranges are often unreliable for female testosterone, with many labs reporting falsely elevated "normal" ranges 1. Your values are actually in the low-normal range, making androgen excess disorders unlikely.

Other Hormone Patterns

FSH (8.7 IU/L) and LH (4.7 IU/L):

  • LH/FSH ratio = 0.54 (normal, <2.5)
  • This ratio does not suggest PCOS, as PCOS typically shows LH/FSH >2.5, though one-third of PCOS patients have normal ratios 1

Estradiol (44 pg/mL):

  • Consistent with early-to-mid follicular phase if menstruating
  • Low if this represents mid-cycle or luteal phase

TSH (0.56 µIU/mL):

  • Low-normal, borderline low
  • Requires free T4 measurement to exclude subclinical hyperthyroidism 3

Prolactin (4.4 ng/mL):

  • Normal (typically <20 ng/mL) 1

Cortisol (7.1 µg/dL):

  • Low-normal for morning sample (normal 5-25 µg/dL)
  • If symptomatic, consider ACTH stimulation test

DHEA-S (170 µg/dL):

  • Normal for age 36 (normal range approximately 35-430 µg/dL) 1, 2

Recommended Next Steps Algorithm

Step 1: Establish Menstrual Cycle Context

Document menstrual pattern over past 6 months:

  • If cycles <23 days: polymenorrhea
  • If cycles >35 days: oligomenorrhea
  • If no bleeding >6 months: amenorrhea 2

Step 2: Repeat Progesterone Correctly

If not already done, obtain progesterone during mid-luteal phase (7 days before expected menses or days 19-23 of 28-day cycle) 1. This single test definitively confirms or excludes ovulation.

Step 3: Complete Thyroid Evaluation

Measure free T4 given borderline low TSH to exclude thyroid dysfunction, which can cause menstrual irregularity 1, 3.

Step 4: Assess for PCOS (if oligomenorrhea/amenorrhea present)

Rotterdam criteria require 2 of 3:

  1. Clinical/biochemical hyperandrogenism (NOT present in your case)
  2. Oligo/anovulation (POSSIBLE if progesterone confirms anovulation)
  3. Polycystic ovaries on ultrasound (NOT yet assessed)

Order transvaginal ultrasound to assess for polycystic ovarian morphology (≥12 follicles 2-9mm or ovarian volume >10mL) 3. However, given normal androgens, PCOS is less likely.

Step 5: Consider Functional Hypothalamic Amenorrhea

If anovulation confirmed with normal androgens, assess for:

  • Excessive exercise
  • Low body weight/eating disorders
  • Psychological stress
  • Recent significant weight loss

These factors suppress GnRH pulsatility, causing low estradiol and anovulation 4.

Step 6: Metabolic Screening (if PCOS suspected)

  • Fasting glucose and insulin
  • Lipid panel
  • Calculate glucose/insulin ratio (>4 suggests insulin resistance) 2

Common Pitfalls to Avoid

  1. Do not diagnose anovulation from a single random progesterone - timing is everything 1

  2. Do not over-interpret normal testosterone as "low" - these values are appropriate for women and do not indicate androgen deficiency requiring treatment

  3. Do not rely on LH/FSH ratio alone for PCOS diagnosis - at least one-third of PCOS patients have normal ratios 1

  4. Do not use ultrasound findings of polycystic ovaries as sole diagnostic criterion - this finding is nonspecific and can occur in normal women, thyroid dysfunction, and hyperprolactinemia 1

  5. Verify laboratory quality for testosterone measurements - many commercial labs use inaccurate assays with unreliable reference ranges for women 1, 5

Clinical Context Matters

Without knowing your menstrual pattern, clinical symptoms (hirsutism, acne, infertility), and cycle day of blood draw, definitive diagnosis is impossible. The low progesterone is only meaningful if drawn at the correct time. If you have regular 28-day cycles and this was drawn on day 5, everything appears normal. If you have 60-day cycles and this was drawn randomly, it confirms anovulation requiring further workup as outlined above.

References

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Guideline

reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Journal of Neurology, Neurosurgery and Psychiatry, 2002

Research

The influence of estro-progestin therapy on neurohormonal activity in functional hypothalamic amenorrhea.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022

Related Questions

What peri‑operative hormone replacement regimen (glucocorticoid and thyroid hormone) is recommended for a 32‑year‑old female with a sellar mass and hemorrhagic infarction presenting with visual disturbance, headache, photophobia, meningismus, peripheral edema, muscle aches, fatigue, depressed mood, dizziness, and recent weight gain?
Interpret the hormone panel (TSH, free T4, T3, DHEA‑S, FSH, free testosterone, LH, progesterone, prolactin, estradiol, cortisol, total testosterone) for a 36‑year‑old woman obtained at mid‑ovulation.
How should I evaluate and manage a 44‑year‑old woman with low free testosterone and low bioavailable testosterone, but normal total testosterone, sex hormone‑binding globulin (SHBG), follicle‑stimulating hormone (FSH), and luteinizing hormone (LH)?
What is the evaluation and management of elevated free testosterone in women?
Is there a laboratory test to identify macro‑TSH?
Is tongkat ali safe for a 58-year-old patient with diabetes mellitus on insulin therapy, chronic kidney disease, and hypertension?
What is the appropriate duration of oral ciprofloxacin therapy for a 50-year-old female with diabetes mellitus and metabolic-associated fatty liver disease who has E. coli septic arthritis?
In a patient without penicillin allergy, which regimen is more effective for bacterial tonsillitis: linezolid 600 mg twice daily or co‑amoxiclav 625 mg (amoxicillin 500 mg + clavulanic acid 125 mg) twice daily?
Can you provide comprehensive information on Spravato (esketamine) nasal spray, including its indications, dosing schedule, administration requirements, monitoring parameters, contraindications, and alternative treatment options?
What is the appropriate medical management for left ventricular outflow tract obstruction?
Does the combined oral contraceptive pill inhibit ovulation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.